Evaluation of CUR-1916 in the patients with Dravet Syndrome.

Trial Profile

Evaluation of CUR-1916 in the patients with Dravet Syndrome.

Planning
Phase of Trial: Phase II

Latest Information Update: 08 Aug 2017

At a glance

  • Drugs CUR 1916 (Primary)
  • Indications Dravet syndrome
  • Focus Adverse reactions
  • Sponsors OPKO Health
  • Most Recent Events

    • 08 Aug 2017 According to an OPKO Health media release, company plans to to file an IND for this trial and expected to begin this study by the end of 2017.
    • 22 Mar 2017 According to an OPKO Health media release, this trial is expected to initiate in 2017.
    • 16 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top